This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

John Theurer Cancer Center hosts New Frontiers in the Management of Solid and Liquid Tumors

October 11th, 2011

John Theurer Cancer Center at Hackensack University Medical Center, one of nation's top 50 best hospitals for cancer, will host the New Frontiers in the Management of Solid and Liquid Tumors on November 3-4 from 7:00am to 4:00pm. This complimentary Continuing Medical Education (CME) program will feature internationally recognized oncologists and hematologists who will provide the latest updates on state-of the-art treatment modalities including novel therapies and new prognostic models in hematological and solid tumors.

"The oncology treatment landscape is rapidly changing," Andre Goy, M.D., M.S., Chairman and Director and Chief of Lymphoma, John Theurer Cancer Center and the program Chair. "This program has been designed to help physicians gain additional insight into how translational research can be applied to the clinic for improved patient outcomes."

Key topics include emerging best practices and ongoing studies in hematological malignancies and solid tumors, the impact of novel therapies in the care of hematology-oncology and solid tumor patients, new modalities in imaging and its best use in cancer patients, biomarkers and new prognostic markers in lymphomas and leukemias, the impact of emerging molecular markers in solid tumors, and the shifting paradigms in the treatment of multiple myeloma. A 15-minute Q&A will follow all presentations.

"This is a great opportunity for physicians and healthcare professionals to hear about the newest research from leading oncology and hematology physicians," Stuart L. Goldberg, M.D., Chief, Leukemia, John Theurer Cancer Center and program Co-Chair. "We are fortunate to have some of the worlds' foremost experts in solid and liquid tumors present information that will guide the development of future therapies."

Featured Speakers and Topics for Thursday, November 3:

  • Volker Diehl, M.D., Professor, University of Cologne, Germany

    Customization: The Treatment of Hodgkin's Disease

  • Jean-Luc Harousseau, M.D., Professor of Hematology, Head, Dept. of Clinical Hematology, Director of the Cancer Center Rene Gauducheau, University of Nantes, France

    Impact of Novel Therapies in the Management of Multiple Myeloma

  • Richard Champlin, M.D., Chair, Dept. of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The Univ. of Texas MD Anderson Cancer Center

    Newest Modalities in Bone Marrow Transplantation

  • Thomas Habermann, M.D., Professor of Medicine, Division of Hematology, Mayo Clinic

    Treatment of Large-Cell Lymphoma

  • Susan O'Brien, M.D., Professor, Dept. of Leukemia, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center

    Newest Strategies in the Treatment of CML/CLL

  • Myron Czuczman, M.D., Professor Chief, Lymphoma/Myeloma Service, Dept. of Medicine Head, Lymphoma Translational Research Laboratory Dept. of Immunology Roswell Park Cancer Center

    Evolving Management of Follicular Lymphoma

Featured Speakers and Topics for Friday, November 4:

  • Shiladitya Sengupta, M.D., Assistant Professor of Medicine and Health Sciences and Technology, Harvard Medical School, Brigham & Women's Hospital

    Personalized Medicine Approaches in Oncology

  • Christoper Logothetis, M.D., Dept. Chair, Dept. of Genitourinary Medical Oncology, Division of Cancer Medicine, the Univ. of Texas MD Anderson Cancer Center

    Current Landscapes in the Management of Prostate Cancer

  • Christopher Azzoli, M.D., Assistant Member, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center

    Current Modalities in the Treatment of Lung Cancer

  • Axel Grothey, M.D., Professor of Oncology; Consultant, Medical Oncology, Mayo Clinic

    New Perspectives in GI Malignancies

  • Kevin R. Fox, M.D., Director, Rena Rowan Breast Center, Perelman Center for Advanced Medicine at Penn Medicine

    Newest Approach to Breast Cancer

  • Steven Horwitz, M.D., Assistant Attending, Lymphoma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center

    Managing T-Cell Lymphoma

"We are committed to providing physicians and healthcare providers with the best educational programs to help clinicians manage today's most complicated cases in cancer," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer and Professor and Vice President of Cancer Services, John Theurer Cancer Center. "I would like to thank Dr. Goy for spearheading this important conference and the impressive panel of experts for presenting at the John Theurer Cancer Center."

Provided by John Theurer Cancer Center

Citation: John Theurer Cancer Center hosts New Frontiers in the Management of Solid and Liquid Tumors (2011, October 11) retrieved 10 August 2026 from https://sciencex.com/wire-news/79789370/john-theurer-cancer-center-hosts-new-frontiers-in-the-management.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
Back to list